HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. [electronic resource]
Producer: 20111206Description: 914-23 p. digitalISSN:- 1573-675X
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Apoptosis -- drug effects
- Blotting, Western
- Caspase 3 -- metabolism
- Caspase 7 -- metabolism
- Cell Cycle Checkpoints
- Cell Line, Tumor
- Cell Proliferation
- Drug Synergism
- Fluorescent Antibody Technique
- Histone Deacetylase Inhibitors -- administration & dosage
- Humans
- Hydroxamic Acids -- administration & dosage
- Indoles -- administration & dosage
- Lymphoma -- drug therapy
- Sulfides -- pharmacology
- Tumor Suppressor Protein p53 -- metabolism
- Valproic Acid -- administration & dosage
- Vorinostat
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.